AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2022 Issue 1; Ask the Editor
Admission for Consolidation Chemotherapy with Bone Marrow Biopsy
A patient with central nervous system 1a, B-cell acute lymphoblastic leukemia (B-ALL) is admitted for intrathecal consolidation chemotherapy. Immediately following chemotherapy, per protocol, an end of induction bone marrow biopsy is performed to evaluate the effectiveness of prior therapy and to determine whether the leukemia is in remission. The Official Guidelines for Coding and Reporting (I.C.2.a.) states, “When treatment is directed at a malignancy, the malignancy is sequenced as the principal diagnosis, except when the admission is solely for chemotherapy.” In this case, the provider clearly documents the reason for admission is the administration of chemotherapy and the bone marrow biopsy was part of the treatment protocol. When a patient is admitted for chemotherapy but also has a diagnostic test such as a biopsy, is the neoplasm assigned as the principal diagnosis instead of code Z51.11, Encounter for antineoplastic chemotherapy? What is the principal diagnosis in this case? ...
Subscribe or sign in to view the full article.
Article Overview
This premium article addresses coding and sequencing considerations for a hospital admission involving consolidation chemotherapy and an associated bone marrow biopsy for a patient with leukemia. It is aimed at coders, CDI specialists, auditors, and billing professionals who need to understand how the admission reason, malignancy status, and a protocol-driven diagnostic procedure may affect diagnosis reporting. The article references the Official Guidelines for Coding and Reporting and focuses on general guidance for principal diagnosis selection in oncology-related inpatient care.
Why This Topic Matters
Admissions for cancer treatment often involve both therapy and diagnostic follow-up, so accurate diagnosis sequencing is important for compliant inpatient reporting and consistent claim submission.
What You Will Learn
- How inpatient admissions for chemotherapy are generally framed for coding review.
- How a protocol-driven biopsy can factor into the overall admission context.
- How oncology-related sequencing guidance is discussed in relation to a treatment admission.
- How to approach documentation when treatment and diagnostic evaluation occur during the same stay.
Who Should Read This
- Inpatient coders
- CDI specialists
- Coding auditors
- Revenue cycle staff
- Billing professionals
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com